Windlas Biotech Limited has informed the Exchange about Copy of Newspaper Publication for Post Buyback Public Announcement
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Windlas Biotech Limited has announced the completion of its share buyback program. The company bought back 4,70,000 fully paid-up equity shares at Rs 1,000 per share, totaling approximately Rs 470 crore. The buyback was conducted on a proportionate basis and complied with SEBI (Buy-back of Securities) Regulations 2018. The post-buyback public advertisement was published on May 16, 2026 in Financial Express (English) and Jansatta and Dainik Bhaskar (Hindi). The buyback price of Rs 1,000 is significantly above the face value of Rs 5 per share.
The buyback reduces the total number of outstanding shares, which increases the ownership percentage for remaining shareholders. The Rs 470 crore cash outflow may impact the company's liquidity position.